1. Home
  2. TFX vs INDV Comparison

TFX vs INDV Comparison

Compare TFX & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teleflex Incorporated

TFX

Teleflex Incorporated

HOLD

Current Price

$134.51

Market Cap

5.3B

Sector

Health Care

ML Signal

HOLD

Logo Indivior PLC

INDV

Indivior PLC

HOLD

Current Price

$37.81

Market Cap

4.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TFX
INDV
Founded
1943
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
4.7B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
TFX
INDV
Price
$134.51
$37.81
Analyst Decision
Buy
Analyst Count
8
0
Target Price
$138.75
N/A
AVG Volume (30 Days)
865.1K
2.0M
Earning Date
05-07-2026
06-08-2026
Dividend Yield
1.02%
N/A
EPS Growth
N/A
8100.00
EPS
N/A
0.69
Revenue
$1,992,713,000.00
$1,239,000,000.00
Revenue This Year
$15.97
N/A
Revenue Next Year
$5.15
N/A
P/E Ratio
N/A
$53.49
Revenue Growth
N/A
4.29
52 Week Low
$100.18
$11.08
52 Week High
$139.67
$41.00

Technical Indicators

Market Signals
Indicator
TFX
INDV
Relative Strength Index (RSI) 61.31 58.90
Support Level $102.20 $29.71
Resistance Level $134.84 $37.83
Average True Range (ATR) 4.18 1.36
MACD 0.08 -0.32
Stochastic Oscillator 91.23 37.98

Price Performance

Historical Comparison
TFX
INDV

About TFX Teleflex Incorporated

Teleflex Inc is a provider of medical technology products focused on enhancing clinical benefits, improving patient and provider safety and reducing total procedural costs. It designs, develops, manufactures and supply medical devices used by hospitals and healthcare providers supporting high-acuity emergent procedures. The company has three reportable segments: Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). It derives maximum revenue from Americas. Its products includes: Anaesthesia, Emergency Medicine, Interventional Cardiology/Radiology, Interventional Urology - UroLift System, Surgery, Urology, and Vascular Access.

About INDV Indivior PLC

Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Share on Social Networks: